Pharmacy Medical News about Amphotericin B

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The current role of amphotericin B lipid complex in managing systemic fungal infections
Current Medical Research and Opinion, 10/26/09

Chu P et al. – ABLC is effective and well–tolerated in the treatment of systemic fungal infections and remains a valuable therapeutic option in a variety of immunocompromised patients due to its broad antifungal spectrum and rarity of resistance.

<< Previous
Pancreatic enzymes for chronic pancreatitis

Next >>
Bioequivalence among three methods of administering pantoprazole...

Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment
Mycoses, 10/29/09 Relevance Score: 69%

Pulmonary Epithelial Lining Fluid Concentrations after Use of Systemic Amphotericin B Lipid Formulations
Antimicrobial Agents and Chemotherapy, 11/05/09 Relevance Score: 68%

Diffuse (anergic) cutaneous leishmaniasis responding to amphotericin B
Clinical and Experimental Dermatology, 11/17/09 Relevance Score: 67%

In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B
Tropical Medicine & International Health, 10/28/09 Relevance Score: 67%

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
Critical Care, 10/20/09 Relevance Score: 66%